LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 73.76 | 771.67 | 7841 | 10851 | 0.7226 | 0.8367 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 73.76 | 771.67 | 6246 | 10851 | 0.5756 | 0.7303 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 76.02 | 771.67 | 8155 | 11106 | 0.7342 | 0.8457 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 76.02 | 771.67 | 6283 | 11106 | 0.5657 | 0.7247 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 78.25 | 771.67 | 8343 | 11367 | 0.7339 | 0.8468 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 78.25 | 771.67 | 6289 | 11367 | 0.5532 | 0.7171 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 80.48 | 771.67 | 8556 | 11685 | 0.7322 | 0.8472 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 80.48 | 771.67 | 6250 | 11685 | 0.5349 | 0.7050 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 82.69 | 771.67 | 8834 | 11974 | 0.7378 | 0.8520 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 82.69 | 771.67 | 6266 | 11974 | 0.5233 | 0.6980 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 84.92 | 771.67 | 8999 | 12266 | 0.7336 | 0.8506 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 84.92 | 771.67 | 6202 | 12266 | 0.5056 | 0.6858 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.14 | 771.67 | 9200 | 12592 | 0.7306 | 0.8501 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.14 | 771.67 | 6170 | 12592 | 0.4900 | 0.6754 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 2.49 | 771.67 | 775 | 867 | 0.8931 | 0.0258 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 2.49 | 771.67 | 824 | 867 | 0.9496 | 0.4734 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.71 | 771.67 | 890 | 956 | 0.9306 | 0.5854 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.71 | 771.67 | 975 | 956 | 1.0195 | 1.1286 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.94 | 771.67 | 976 | 1045 | 0.9339 | 0.7105 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.94 | 771.67 | 1053 | 1045 | 1.0075 | 1.0346 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 9.16 | 771.67 | 1041 | 1138 | 0.9144 | 0.7050 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 9.16 | 771.67 | 1132 | 1138 | 0.9943 | 0.9797 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 11.56 | 771.67 | 1156 | 1280 | 0.9027 | 0.7386 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 11.56 | 771.67 | 1263 | 1280 | 0.9862 | 0.9624 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 13.78 | 771.67 | 1268 | 1459 | 0.8686 | 0.7160 | MN20160304_L01 | D10 |